Navigation Links
Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
Date:9/12/2007

re consistent with the increased glucose control observed in diabetes animal models where a short treatment with E1-I.N.T.(TM) resulted in a sustained increase in beta cell mass and function. These clinical improvements, including HbA1c reductions greater than 1% in patients six month post-treatment, highlight the potential that E1-I.N.T.(TM) therapy could provide patients significant clinical benefit in excess of six months.

These clinical data support the potential of gastrin as a therapeutic in combination with other diabetes therapies. Transition holds the exclusive rights to a series of proprietary gastrin based combination therapies including GLP1-I.N.T.(TM) (a combination of gastrin analogue, G1, and a GLP-1 analogue) and combination therapies of gastrins and DPP-IV inhibitors. Transition will continue the development of these combination therapies into clinical trials with type 1 and type 2 diabetes patients.

GLP1- I.N.T.(TM)

Transition's second Islet Neogenesis Therapy product, GLP1-I.N.T.(TM) is a combination of one of the leading diabetes drug candidates, Glucagon-Like-Peptide-1 ("GLP-1"), with G1. The Company will perform additional safety and tolerability studies in humans in preparation for Phase II clinical development. The Company has entered into an agreement with the JDRF to support the clinical development of GLP1-I.N.T.(TM) over the next two years.

Sustaining Financial Strength

-----------------------------

During the year ended June 30, 2007, the Company strengthened its cash position by completing an offering for 2,986,867 common shares for net cash proceeds of $23,964,751. Subsequent to the end of the year, the Company further strengthened its cash position by completing another private placement, issuing 1,736,107 common shares resulting in net cash proceeds of $23,976,404. The Company's cash and cash equivalents and short-term investments were $34,368,142 at June 30, 2007. The Company currently believes th
'/>"/>

SOURCE Transition Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Mans Transition from Foragers to Agriculturalist Led to Increase in Birth Rates
2. Rocky Transition to the Medicare Drug Program
3. Customized Post Operation Care Offers Patients a Smooth Transition to Patients into the Community
4. Mental Health - NHS Trust Commences Specialist Transition Service
5. Permanent Weight Loss Requires Transition to Healthy Eating
6. VBI Provides Potential Targets to Diabetes Therapeutics
7. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
8. PM announces a new health care order for India
9. Ramdoss Announces Introduction of RCH-II
10. Britain Announces Third Transfusion Related Mad Cow Case
11. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 Getting breast implants is ... completely optional or due to medical necessity. Either way, women ... to prepare for it, says Robert Kraft, MD, Plastic Surgeon ... implant removal surgeries are performed each year in the United ... 70 percent of those procedures stem from three main problems: ...
(Date:7/22/2014)... The hair transplant experts at WeGrowHair.com / PAI ... therapy and robotic assisted hair transplantation to provide ... from hair loss. Alongside their unique Multi-Unit Hair ... (FUE) procedures via ARTAS – the world’s most ... doctors use advanced digital mapping to more accurately ...
(Date:7/21/2014)... target and kill cancer cells could boost the effectiveness ... avoid amputation, a new study reports. , Scientists at ... of a genetically engineered version of the virus used ... the virus alongside isolated limb perfusion chemotherapy given ... leg as an alternative to amputation was more ...
(Date:7/21/2014)... MillionaireCasket.com, a well-known casket manufacturer from China, has recently added ... website. In addition to this, the company is now giving ... brand new items. , MillionaireCasket.com is a reliable supplier ... for its current and prospective clients. Its hot products include ... more. According to the company’s sales manager, its website will ...
(Date:7/21/2014)... 21, 2014 Cannabis Now Magazine recently ... events this summer. During these festivals, they will strengthen ... information and resources to attendees in an effort to ... on the legitimate and beneficial side of cannabis. , ... San Francisco, the Kush Expo in Anaheim, the Champs ...
Breaking Medicine News(10 mins):Health News:Is Breast Implant Removal Right for You? Plastic Surgeon Dr. Robert Kraft With Advanced Dermatology, PC Explains Breast Implant Removal and Offers Tips On Procedure 2Health News:Is Breast Implant Removal Right for You? Plastic Surgeon Dr. Robert Kraft With Advanced Dermatology, PC Explains Breast Implant Removal and Offers Tips On Procedure 3Health News:WeGrowHair.com/PAI Medical Group Introduces Robotic Assisted Laser Therapy to Treat Hair Loss 2Health News:Viral therapy could boost limb-saving cancer treatment 2Health News:Viral therapy could boost limb-saving cancer treatment 3Health News:Cheap Maple Caskets Recently Added To China Casket Manufacturer MillionaireCasket.com’s Product Line 2Health News:Cannabis Now Magazine Hits the Marijuana Festival Circuit and Sponsors Two Major Events 2
... history data supports heredity,s role in shoulder tendon tearsROSEMONT, Ill., ... rotator cuff tears are at increased risk ... in the May 2009 issue of The Journal ... "This strongly suggests genetic predisposition as a possible cause for ...
... Enables Hospitals to Rapidly Notify Staff, Community and Authorities with Instant ... ... 1, 2009 -- Mobile Health Tech, the healthcare division of Gold ... Rapid Notification Alert System™. This new release allows hospitals to provide ...
... Inc. (NYSE Amex: DDD ) reported financial results ... Company will host a live conference call on May 1, ... Pharma,s President and CEO, stated, "Our top priorities continue to ... and pseudoephedrine, and the support of our existing alliances and ...
... with CDC Treatment Guidelines at the Point of ... a leading developer of drug information applications and ... e-prescribing solution EMPOWERx is now providing physicians with ... Virus as issued by the Centers for Disease ...
... HULL, England, May 1 Smith & Nephew,s Advanced Wound Management ... Patents Court, in the High Court of Justice of England and ... asserted against Smith & Nephew of the Negative Pressure Wound Therapy ... (KCI) (NYSE: KCI ). The 3 other claims ...
... N.M., May 1 Strategic Analytics Inc., the leading ... lenders, today disclosed that its LookAhead(TM) software was used ... federal regulators. Strategic Analytics software and services are used ... largest U.S. consumer loan portfolios, according to American Banker.Several ...
Cached Medicine News:Health News:Rotator Cuff Tears: Are They All in the Family? 2Health News:Rotator Cuff Tears: Are They All in the Family? 3Health News:Hospital Rapid Alert System Supports Swine Flu Pandemic Communications 2Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 2Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 3Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 4Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 5Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 6Health News:SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results 7Health News:EMPOWERx E-Prescribing Solution Provides Latest Treatment Guidelines for 2008-2009 H1N1 Influenza Virus 2Health News:Smith & Nephew Encouraged by United Kingdom NPWT Patent Court Decision 2Health News:Smith & Nephew Encouraged by United Kingdom NPWT Patent Court Decision 3Health News:Strategic Analytics Reports Stress Test Achievements 2Health News:Strategic Analytics Reports Stress Test Achievements 3
(Date:7/21/2014)... , July 21, 2014 /PRNewswire-iReach/ -- Top Brooklyn ... Pediatrics responds to an article, which suggests that caffeine ... Logo - http://photos.prnewswire.com/prnh/20140718/128611 A ... giving coffee to children, but now it happens rather ... A new study, published in the journal Pediatrics, discussed ...
(Date:7/21/2014)... , July 21, 2014 ... Transparency Market Research "E-Clinical Solution Software Market- Global Industry ... 2020," the global microfluidic device market was valued at ... grow at a CAGR of 13.8% from 2014 to ... million in 2020. Browse the full E-Clinical ...
(Date:7/21/2014)... Conn. , July 21, 2014 UBM ... , a leading online community for primary care ... help clinicians identify and treat victims of a variety ... of summer are packed with a host of medical ... name a few. Some of the highlights covered on ...
Breaking Medicine Technology:Dr. Michael Gabriel a Brooklyn Pediatrician Comments on an Article, Which Suggests Caffeine May Be Dangerous for Children 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5ConsultantLive Presents Special Coverage of Summer Scourges 2ConsultantLive Presents Special Coverage of Summer Scourges 3
... 9, 2012  Unigene Laboratories, Inc. (OTCBB: UGNE) ... multiple near-term catalysts that have the potential to monetize ... months.  Management believes the key elements are in place ... balance sheet in 2012.  Unigene,s CEO, Senior Management and ...
... 2012  Robert McNally, Ph.D., President and CEO of GeoVax Labs, ... Dear Fellow Shareholders, At the start ... that we have accomplished over the past year, but it ... challenges and opportunities awaiting GeoVax in 2012 and beyond. ...
Cached Medicine Technology:Unigene Provides 2012 Business Outlook 2Unigene Provides 2012 Business Outlook 3Unigene Provides 2012 Business Outlook 4Unigene Provides 2012 Business Outlook 5Unigene Provides 2012 Business Outlook 6Unigene Provides 2012 Business Outlook 7Unigene Provides 2012 Business Outlook 8Unigene Provides 2012 Business Outlook 9Unigene Provides 2012 Business Outlook 10Unigene Provides 2012 Business Outlook 11GeoVax Labs' CEO Update Letter to Shareholders 2GeoVax Labs' CEO Update Letter to Shareholders 3GeoVax Labs' CEO Update Letter to Shareholders 4GeoVax Labs' CEO Update Letter to Shareholders 5
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
... Smith & Nephew ECTRA II systems permit ... carpal tunnel ligament endoscopically, allowing access via ... while minimizing endoscopic lens fogging with good ... complete visualization and control. ECTRA knives permit ...
Medicine Products: